2.63 USD
↘ 0.38 (12.62%)AT CLOSE (03:59 PM EST)
OnKure Therapeutics, Inc. Class A Common Stock
OKURNASDAQ • USD
2.63
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EST)
Post Market
AS OF 07:59 PM EST
2.63
↗ 0.00 (0.00%)
Market: CLOSED
Shares of OnKure Therapeutics, Inc. Class A Common Stock (OKUR) are trading at $2.63. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, OKUR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.
Open?$3.03
High?$3.08
Low?$2.60
Prev. Close?$3.01
Volume?891.4K
Avg. Volume?395.1K
VWAP?$2.78
Rel. Volume?2.26x
Bid / Ask
Bid?$2.50 × 1.0K
Ask?$3.62 × 100
Spread?$1.12
Midpoint?$3.06
Valuation & Ratios
Market Cap?108.3M
Shares Out?N/A
Float?24.9M
Float %?61.7%
P/E Ratio?N/A
P/B Ratio?0.69
EPS?-$1.50
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Employees
45
Market Cap
108.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-07
Address
6707 WINCHESTER CIRCLE, SUITE 400
BOULDER, CO 80301
Phone: (720) 307-2892
BOULDER, CO 80301
Phone: (720) 307-2892
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?96
Momentum?50
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?4.58Safe
Confidence?36%Very Low
Short InterestElevated
Short % of Float?5.21%Elevated
Short Interest?1.3M
Days to Cover?4.2
Free Float24.9M
Avg Daily Volume306.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?18.84Strong
Quick Ratio?18.84Strong
Cash Ratio?17.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.69CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.7CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-39.2%WEAK▾
S&P3
ROA?-37.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-47935000
Enterprise Value?$-43114297
Fundamentals ratios updated end of day